XML 73 R60.htm IDEA: XBRL DOCUMENT
v3.21.1

Commitments and Contingencies - Additional Information (Detail) $ in Millions | 1 Months Ended | 3 Months Ended
--- | --- | ---
May 31, 2021 PutativeClassAction | Apr. 30, 2021 PutativeClassAction | Mar. 31, 2021 USD ($)
Commitments And Contingencies [Line Items] |  |  |
Outstanding non-cancelable purchase obligations |  |  | $ 93.9
Subsequent Event [Member] |  |  |
Commitments And Contingencies [Line Items] |  |  |
Putative securities class action complaints filed | PutativeClassAction | 2 | 3 |
Manufacture and Supply of Roxadustat [Member] |  |  |
Commitments And Contingencies [Line Items] |  |  |
Outstanding non-cancelable purchase obligations |  |  | 30.4
Manufacture and Supply of Pamrevlumab [Member] |  |  |
Commitments And Contingencies [Line Items] |  |  |
Outstanding non-cancelable purchase obligations |  |  | 57.5
Other Purchases [Member] |  |  |
Commitments And Contingencies [Line Items] |  |  |
Outstanding non-cancelable purchase obligations |  |  | 6.0
Research and Pre-Clinical Stage Development Programs [Member] |  |  |
Commitments And Contingencies [Line Items] |  |  |
Maximum future milestone payments |  |  | $ 10.9

X
- Definition Commitments and contingencies. + References No definition available. + Details
Name: | fgen_CommitmentsAndContingenciesLineItems
Namespace Prefix: | fgen_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum future milestone payments. + References No definition available. + Details
Name: | fgen_MaximumFutureMilestonePayments
Namespace Prefix: | fgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. + References No definition available. + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The total number of new claims filed pertaining to a loss contingency during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 + Details
Name: | us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=fgen_ManufactureAndSupplyOfRoxadustatMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=fgen_ManufactureAndSupplyOfPamrevlumabMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=fgen_OtherPurchasesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=fgen_ResearchAndPreClinicalStageDevelopmentProgramsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |